No abstract available
Keywords:
Rituxan; Treanda; Zydelig; adverse effects; bendamustine; dosage; drug interactions; efficacy; idelalisib; pregnancy; rituximab; safety.
MeSH terms
-
Antineoplastic Agents / administration & dosage*
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / economics
-
Drug Costs
-
Drug Interactions
-
Humans
-
Lymphoma, Follicular / drug therapy*
-
Lymphoma, Follicular / pathology
-
Phosphatidylinositol 3-Kinase / metabolism
-
Phosphoinositide-3 Kinase Inhibitors*
-
Protein Kinase Inhibitors / administration & dosage*
-
Protein Kinase Inhibitors / adverse effects
-
Protein Kinase Inhibitors / economics
-
Pyrimidines / administration & dosage*
-
Pyrimidines / adverse effects
-
Pyrimidines / economics
-
Quinazolines / administration & dosage*
-
Quinazolines / adverse effects
-
Quinazolines / economics
-
Recurrence
-
Signal Transduction / drug effects
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Phosphoinositide-3 Kinase Inhibitors
-
Protein Kinase Inhibitors
-
Pyrimidines
-
Quinazolines
-
Phosphatidylinositol 3-Kinase
-
copanlisib